# Observational Prospective Study on Patients Treated With Norditropin®

> **NCT00960128** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 21249 (actual)

## Conditions studied

- Growth Hormone Disorder
- Growth Hormone Deficiency in Children
- Adult Growth Hormone Deficiency
- Genetic Disorder
- Turner Syndrome
- Foetal Growth Problem
- Small for Gestational Age
- Chronic Kidney Disease
- Chronic Renal Insufficiency
- Noonan Syndrome

## Interventions

- **DRUG:** somatropin
- **DRUG:** somatropin

## Key facts

- **NCT ID:** NCT00960128
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-04-01
- **Primary completion:** 2016-12-31
- **Final completion:** 2016-12-31
- **Target enrollment:** 21249 (ACTUAL)
- **Last updated:** 2017-10-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00960128

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00960128, "Observational Prospective Study on Patients Treated With Norditropin®". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00960128. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*